Vijay Kuchroo

28PUBLICATIONS
163CO-AUTHORS
Molecular targetsAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reinforcement learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.

|Apr 24, 2026
An adaptive cellular source of IL-17A and IL-17F is critical for the induction of experimental autoimmune encephalomyelitis.

|Apr 13, 2026
The dual role of TOX in regulating TH1 and CD8+ T cell fate.

Yoon-Chul Kye, Vijay K Kuchroo

|Mar 31, 2026
Inhibitory receptor agonists: Emerging strategies in immune modulation.

Kieran R Adam, Aamir Suhail, Vijay K Kuchroo

|Mar 28, 2026
Author Correction: Circadian circuits control plasticity of group 3 innate lymphoid cells by sustaining epigenetic configuration of RORγt.

Bishan Bhattarai, Alina Ulezko Antonova, Jose L Fachi

|Aug 13, 2025
Circadian circuits control plasticity of group 3 innate lymphoid cells by sustaining epigenetic configuration of RORγt.

Bishan Bhattarai, Alina Ulezko Antonova, Jose L Fachi

Pageof 5

Frequent Collaborators

8 joint publications

Aviv Regev

6 joint publications

Orit Rozenblatt-Rosen

6 joint publications

Karen O Dixon

5 joint publications

Alexandra Schnell